VR Adviser »

Achieve Life Sciences shares owned by VR Adviser

Quarter-by-quarter ownership of Achieve Life Sciences (ACHV) shares owned by VR Adviser from 13F filings

Historical chart of VR Adviser investment in Achieve Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Achieve Life Sciences held by VR Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achieve Life Sciences by VR Adviser

Quarter filed Position value Share count Share price at filing
2026-06-30 $18M 2.8M 6.53

More positions owned by VR Adviser

Apogee Therapeutics (APGE)
Oruka Therapeutics (ORKA)
Erasca (ERAS)
Spyre Therapeutics Com New (SYRE)
Dianthus Therapeutics (DNTH)
Ocular Therapeutix (OCUL)
Damora Therapeutics Com New (DMRA)
Savara (SVRA)
Jade Biosciences Com New (JBIO)
Cogent Biosciences (COGT)
Miragen Therapeutics (VRDN)
Vor Biopharma Com New (VOR)
Dyne Therapeutics (DYN)
Maze Therapeatics (MAZE)
Relmada Therapeutics (RLMD)

View all positions for VR Adviser

Top funds holding Achieve Life Sciences

venBio Partners
Franklin Resources
Vanguard Capital Management
Propel Bio Management
Marshall Wace
Jupiter Topco
VR Adviser
Simplify Asset Management
Millennium Management
Spruce Street Capital
LPL Financial
Raymond James Financial
Geode Capital Management
Vanguard Fiduciary Trust
Two Sigma Investments

View all funds holding Achieve Life Sciences